Coeptis Therapeutics Holdings, Inc. (COEP)의 가격은 얼마입니까?

Coeptis Therapeutics Holdings, Inc. (COEP)의 가격은 $4.81입니다.

Coeptis Therapeutics Holdings, Inc. (COEP)의 시가 총액은 무엇입니까?

Coeptis Therapeutics Holdings, Inc. (COEP)의 시가 총액은 $29.01M입니다.

Coeptis Therapeutics Holdings, Inc. (COEP) 주당순이익

Coeptis Therapeutics Holdings, Inc., together with its subsidiaries, operates as a biopharmaceutical and technology company. The company is developing cell therapy platforms for cancer, autoimmune, and infectious diseases. Its therapeutic portfolio includes an allogeneic cellular immunotherapy platform; and DVX201, a clinical-stage, unmodified natural killer cell therapy technology. The company’s product pipeline consists of CD38-GEAR-NK, a cell therapy for the treatment of CD38-related cancers, including multiple myeloma, chronic lymphocytic leukemia, and acute myeloid leukemia; CD38-Diagnostic, an in vitro screening tool to analyze cancer patients if cancer patients might be appropriate candidates for anti-CD38 mAb therapy; and SNAP-CAR, a chimeric antigen receptor (CAR) therapy for treatment for cancer. In addition, the company offers its drugs for acute myeloid leukemia and acute respiratory diseases. Coeptis Therapeutics Holdings, Inc. has co-development agreement Vici Health Sciences, LLC to co-develop and share ownership rights to CPT60621 for the treatment of Parkinson’s Disease. The company was founded in 2017 and is headquartered in Wexford, Pennsylvania.

연도	EPS	변화
제공된 날짜에 대한 데이터가 충분하지 않습니다.

연도

EPS

변화

제공된 날짜에 대한 데이터가 충분하지 않습니다.

회사	EPS	EPS 차이	국가
Vertex Pharmaceuticals Incorporated VRTX.US	$17.32	-	US
Moderna, Inc. MRNA.US	$-7.98	-	US
Argenx SE ARGX.US	$27.74	-	NL
CSL Limited CSL.AX	$2.98	-	AU
Lonza Group AG LONN.SW	-	-	CH

회사

EPS

EPS 차이

국가